Agios Pharmaceuticals, Inc. (8AP.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:03AM CEST. Market open.
Show:
Annual
Cash Flow
Currency in USD. All numbers in thousandsBreakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-352,619
-352,088
-231,801
1,604,715
-327,370
-
Depreciation & amortization
6,181
6,623
8,564
9,240
9,790
-
Stock based compensation
43,861
44,766
49,296
53,508
61,602
-
Change in working capital
-22,266
-19,057
-16,433
-36,822
1,965
-
Accounts receivable
-1,675
-604
-2,206
0
-10,060
-
Inventory
-11,696
-10,584
-8,492
0
-7,367
-
Accounts Payable
2,493
-8,733
3,436
1,863
3,330
-
Other working capital
-318,987
-314,561
-314,359
-413,061
-304,865
-
Other non-cash items
28,415
28,220
-117,858
9,537
8,982
-
Net cash provided by operating activites
-300,746
-296,062
-309,478
-407,320
-290,759
-
Cash flows from investing activities
Investments in property, plant and equipment
-18,241
-18,499
-4,881
-5,741
-14,106
-
Purchases of investments
-533,638
-417,930
-1,030,781
-1,378,221
-557,030
-
Sales/Maturities of investments
857,205
674,679
1,146,175
829,804
647,685
-
Other investing activites
-
-
131,784
-
-
-
Net cash used for investing activites
306,541
239,575
243,261
1,248,778
75,746
-
Cash flows from financing activities
Debt repayment
-
0
-331
-578
-336
-
Common stock issued
-
-
-
0
0
277,201
Common stock repurchased
-
0
0
-802,486
0
-
Other financing activites
-
-
-
-
250,537
-
Net cash used privided by (used for) financing activities
8,830
5,433
2,350
-765,768
10,981
-
Net change in cash
14,625
-51,054
-63,867
75,690
46,505
-
Cash at beginning of period
104,139
139,259
203,126
127,436
80,931
-
Cash at end of period
118,764
88,205
139,259
203,126
127,436
-
Free Cash Flow
Operating Cash Flow
-300,746
-296,062
-309,478
-407,320
-290,759
-
Capital Expenditure
-18,241
-18,499
-4,881
-5,741
-14,106
-
Free Cash Flow
-318,987
-314,561
-314,359
-413,061
-304,865
-
© 2024 Yahoo. All rights reserved.